{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:30:53Z","timestamp":1784043053441,"version":"3.55.0"},"reference-count":30,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,1]]},"abstract":"<jats:sec>\n<jats:title>OBJECTIVE<\/jats:title>\n<jats:p>Tuberous sclerosis is a rare genetic condition caused by <jats:italic>TSC1<\/jats:italic> or <jats:italic>TSC2<\/jats:italic> mutations that can be inherited, sporadic, or the result of somatic mosaicism. Subependymal giant-cell astrocytoma (SEGA) is a major diagnostic feature of tuberous sclerosis complex (TSC). This study aimed to present a series of cases in which a pathological diagnosis of SEGA was not diagnostic of tuberous sclerosis.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>METHODS<\/jats:title>\n<jats:p>The authors retrospectively reviewed a clinical case series of 5 children who presented with a SEGA tumor to Johns Hopkins All Children\u2019s Hospital and St. Louis Children\u2019s Hospital between 2010 and 2022 and whose initial genetic workup was negative for tuberous sclerosis. All patients were treated with craniotomy for SEGA resection. <jats:italic>TSC<\/jats:italic> genetic testing was performed on all SEGA specimens.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>RESULTS<\/jats:title>\n<jats:p>The children underwent open frontal craniotomy for SEGA resection from the ages of 10 months to 14 years. All cases demonstrated the classic imaging features of SEGA. Four were centered at the foramen of Monro and 1 in the occipital horn. One patient presented with hydrocephalus, 1 with headaches, 1 with hand weakness, 1 with seizures, and 1 with tumor hemorrhage. Somatic <jats:italic>TSC1<\/jats:italic> mutation was present in the SEGA tumors of 2 patients and <jats:italic>TSC2<\/jats:italic> mutation in 1 patient. Germline TSC mutation testing was negative for all 5 cases. No patient had other systemic findings of tuberous sclerosis on ophthalmological, dermatological, neurological, renal, or cardiopulmonary assessments and thus did not meet the clinical criteria for tuberous sclerosis. The average follow-up was 6.7 years. Recurrence was noted in 2 cases, in which 1 patient underwent radiosurgery and 1 was started on a mammalian target of rapamycin (mTOR) inhibitor (rapamycin).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>CONCLUSIONS<\/jats:title>\n<jats:p>There may be intracranial implications of somatic mosaicism associated with tuberous sclerosis. Children who are diagnosed with SEGA do not necessarily have a diagnosis of tuberous sclerosis. Tumors may carry a <jats:italic>TSC1<\/jats:italic> or <jats:italic>TSC2<\/jats:italic> mutation, but germline testing can be negative. These children should continue to be followed with serial cranial imaging for tumor progression, but they may not require the same long-term monitoring as patients who are diagnosed with germline <jats:italic>TSC1<\/jats:italic> or <jats:italic>TSC2<\/jats:italic> mutations.<\/jats:p>\n<\/jats:sec>","DOI":"10.3171\/2023.5.peds23108","type":"journal-article","created":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T18:52:20Z","timestamp":1686423140000},"page":"351-357","source":"Crossref","is-referenced-by-count":5,"title":["Subependymal giant-cell astrocytomas in the absence of tuberous sclerosis"],"prefix":"10.3171","volume":"32","author":[{"given":"Rebecca A.","family":"Reynolds","sequence":"first","affiliation":[{"name":"Division of Pediatric Neurosurgery, Johns Hopkins All Children\u2019s Hospital, St. Petersburg, Florida;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane J.","family":"Aum","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Gonzalez-Gomez","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins All Children\u2019s Hospital, St. Petersburg, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wong","sequence":"additional","affiliation":[{"name":"Neurology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaleigh","family":"Roberts","sequence":"additional","affiliation":[{"name":"Pathology, Washington University in St. Louis, St. Louis, Missouri; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonika","family":"Dahiya","sequence":"additional","affiliation":[{"name":"Pathology, Washington University in St. Louis, St. Louis, Missouri; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis F.","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"Division of Pediatric Neurosurgery, Johns Hopkins All Children\u2019s Hospital, St. Petersburg, Florida;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarod L.","family":"Roland","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Smyth","sequence":"additional","affiliation":[{"name":"Division of Pediatric Neurosurgery, Johns Hopkins All Children\u2019s Hospital, St. Petersburg, Florida;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1","series-title":"Nat Rev Dis Primers","first-page":"16035","article-title":"Tuberous sclerosis complex","volume":"2","author":"Henske EP","year":"2016","unstructured":"Henske EP, J\u00f3\u017awiak S, Kingswood JC, Sampson JR, Thiele EA. Tuberous sclerosis complex. Nat Rev Dis Primers. 2016;2:16035."},{"issue":"3","key":"b2","series-title":"Folia Neuropathol","first-page":"139","article-title":"Brain lesions in tuberous sclerosis complex","volume":"48","author":"Grajkowska W","year":"2010","unstructured":"Grajkowska W, Kotulska K, Jurkiewicz E, Matyja E. Brain lesions in tuberous sclerosis complex. Folia Neuropathol. 2010;48(3):139\u2013149."},{"issue":"4","key":"b3","series-title":"Pediatr Neurol","first-page":"243","article-title":"Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Northrup H","year":"2013","unstructured":"Northrup H, Krueger DA. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. 2013;49(4):243\u2013254."},{"key":"b4","series-title":"Pediatr Neurol","first-page":"50","article-title":"Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations","volume":"123","author":"Northrup H","year":"2021","unstructured":"Northrup H, Aronow ME, Bebin EM,  Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations. Pediatr Neurol. 2021;123:50\u201366."},{"issue":"5327","key":"b5","series-title":"Science","first-page":"805","article-title":"Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34","volume":"277","author":"van Slegtenhorst M","year":"1997","unstructured":"van Slegtenhorst M, de Hoogt R, Hermans C,  Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science. 1997;277(5327):805\u2013808."},{"issue":"2","key":"b6","series-title":"J Pathol","first-page":"219","article-title":"New developments in the genetics and pathogenesis of tumours in tuberous sclerosis complex","volume":"241","author":"Lam HC","year":"2017","unstructured":"Lam HC, Nijmeh J, Henske EP. New developments in the genetics and pathogenesis of tumours in tuberous sclerosis complex. J Pathol. 2017;241(2):219\u2013225."},{"issue":"7","key":"b7","series-title":"Cell","first-page":"1305","article-title":"Identification and characterization of the tuberous sclerosis gene on chromosome 16","volume":"75","author":"European Chromosome 16 Tuberous Sclerosis Consortium","year":"1993","unstructured":"European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell. 1993;75(7):1305\u20131315."},{"issue":"11","key":"b8","series-title":"PLoS Genet","first-page":"e1005637","article-title":"Mosaic and intronic mutations in TSC1\/TSC2 explain the majority of TSC patients with no mutation identified by conventional testing","volume":"11","author":"Tyburczy ME","year":"2015","unstructured":"Tyburczy ME, Dies KA, Glass J,  Mosaic and intronic mutations in TSC1\/TSC2 explain the majority of TSC patients with no mutation identified by conventional testing. PLoS Genet. 2015;11(11):e1005637."},{"issue":"11","key":"b9","series-title":"Nat Neurosci","first-page":"1504","article-title":"Somatic mosaicism and neurodevelopmental disease","volume":"21","author":"D\u2019Gama AM","year":"2018","unstructured":"D\u2019Gama AM, Walsh CA. Somatic mosaicism and neurodevelopmental disease. Nat Neurosci. 2018;21(11):1504\u20131514."},{"issue":"12","key":"b10","series-title":"Am J Med Genet A","first-page":"3851","article-title":"Low-level mosaicism in tuberous sclerosis complex in four unrelated patients: comparison of clinical characteristics and diagnostic pathways","volume":"185","author":"Manzanilla-Romero HH","year":"2021","unstructured":"Manzanilla-Romero HH, Weis D, Schnaiter S, Rudnik-Sch\u00f6neborn S. Low-level mosaicism in tuberous sclerosis complex in four unrelated patients: comparison of clinical characteristics and diagnostic pathways. Am J Med Genet A. 2021;185(12):3851\u20133858."},{"issue":"2","key":"b11","series-title":"Acta Cytol","first-page":"171","article-title":"Cytomorphology of subependymal giant cell astrocytoma","volume":"36","author":"Altermatt HJ","year":"1992","unstructured":"Altermatt HJ, Scheithauer BW. Cytomorphology of subependymal giant cell astrocytoma. Acta Cytol. 1992;36(2):171\u2013175."},{"issue":"1","key":"b12","series-title":"Neuropathology","first-page":"25","article-title":"Subependymal giant cell astrocytoma (SEGA): Is it an astrocytoma? Morphological, immunohistochemical and ultrastructural study","volume":"29","author":"Buccoliero AM","year":"2009","unstructured":"Buccoliero AM, Franchi A, Castiglione F,  Subependymal giant cell astrocytoma (SEGA): Is it an astrocytoma? Morphological, immunohistochemical and ultrastructural study. Neuropathology. 2009;29(1):25\u201330."},{"issue":"5","key":"b13","series-title":"Childs Nerv Syst","first-page":"961","article-title":"Identification of TSC1 or TSC2 mutation limited to the tumor in three cases of solitary subependymal giant cell astrocytoma using next-generation sequencing technology","volume":"36","author":"Fohlen M","year":"2020","unstructured":"Fohlen M, Harzallah I, Polivka M,  Identification of TSC1 or TSC2 mutation limited to the tumor in three cases of solitary subependymal giant cell astrocytoma using next-generation sequencing technology. Childs Nerv Syst. 2020;36(5):961\u2013965."},{"key":"b14","series-title":"Pediatr Neurol","first-page":"38","article-title":"TSC1 mosaicism leading to subependymal giant cell astrocytoma but not tuberous sclerosis complex","volume":"123","author":"Hall A","year":"2021","unstructured":"Hall A, Westlake G, Short BP, Pearson M, Ess KC. TSC1 mosaicism leading to subependymal giant cell astrocytoma but not tuberous sclerosis complex. Pediatr Neurol. 2021;123:38\u201339."},{"issue":"1","key":"b15","series-title":"Clin Neuropathol","first-page":"6","article-title":"Story of the solitary subependymal giant cell astrocytoma: a case report and literature review","volume":"41","author":"Khan M","year":"2022","unstructured":"Khan M, Guzman MA, Tanios A. Story of the solitary subependymal giant cell astrocytoma: a case report and literature review. Clin Neuropathol. 2022;41(1):6\u201311."},{"issue":"4","key":"b16","series-title":"Childs Nerv Syst","first-page":"1381","article-title":"A case of subependymal giant cell astrocytoma without tuberous sclerosis complex and review of the literature","volume":"37","author":"O\u2019Rawe M","year":"2021","unstructured":"O\u2019Rawe M, Chandran AS, Joshi S, Simonin A, Dyke JM, Lee S. A case of subependymal giant cell astrocytoma without tuberous sclerosis complex and review of the literature. Childs Nerv Syst. 2021;37(4):1381\u20131385."},{"issue":"4","key":"b17","series-title":"Childs Nerv Syst","first-page":"1357","article-title":"A case of solitary subependymal giant cell astrocytoma with histopathological anaplasia and TSC2 gene alteration","volume":"37","author":"Suzuki M","year":"2021","unstructured":"Suzuki M, Kondo A, Ogino I,  A case of solitary subependymal giant cell astrocytoma with histopathological anaplasia and TSC2 gene alteration. Childs Nerv Syst. 2021;37(4):1357\u20131362."},{"issue":"4","key":"b18","series-title":"J Mol Diagn","first-page":"544","article-title":"A case of solitary subependymal giant cell astrocytoma: two somatic hits of TSC2 in the tumor, without evidence of somatic mosaicism","volume":"7","author":"Ichikawa T","year":"2005","unstructured":"Ichikawa T, Wakisaka A, Daido S,  A case of solitary subependymal giant cell astrocytoma: two somatic hits of TSC2 in the tumor, without evidence of somatic mosaicism. J Mol Diagn. 2005;7(4):544\u2013549."},{"issue":"1","key":"b19","series-title":"Childs Nerv Syst","first-page":"77","article-title":"TSC2 somatic mosaic mutation, including extra-tumor tissue, may be the developmental cause of solitary subependymal giant cell astrocytoma","volume":"38","author":"Sasaki T","year":"2022","unstructured":"Sasaki T, Uda T, Kuki I,  TSC2 somatic mosaic mutation, including extra-tumor tissue, may be the developmental cause of solitary subependymal giant cell astrocytoma. Childs Nerv Syst. 2022;38(1):77\u201383."},{"issue":"1","key":"b20","series-title":"Radiol Case Rep","first-page":"180","article-title":"A solitary extraventricular subependymal giant cell astrocytoma in the absence of tuberous sclerosis","volume":"16","author":"Tompe AP","year":"2021","unstructured":"Tompe AP, Sargar KM, Kazmi SAJ, Shimony N. A solitary extraventricular subependymal giant cell astrocytoma in the absence of tuberous sclerosis. Radiol Case Rep. 2021;16(1):180\u2013184."},{"key":"b21","series-title":"Tuberous Sclerosis Complex: Genes, Clinical Features and Therapeutics","author":"Kwiatkowski DJ","year":"2011","unstructured":"Kwiatkowski DJ, Whittemore VH, Thiele EA, eds. Tuberous Sclerosis Complex: Genes, Clinical Features and Therapeutics. John Wiley & Sons; 2011."},{"issue":"10","key":"b22","series-title":"JAMA Dermatol","first-page":"1095","article-title":"Dermatologic and dental aspects of the 2012 International Tuberous Sclerosis Complex Consensus Statements","volume":"150","author":"Teng JM","year":"2014","unstructured":"Teng JM, Cowen EW, Wataya-Kaneda M,  Dermatologic and dental aspects of the 2012 International Tuberous Sclerosis Complex Consensus Statements. JAMA Dermatol. 2014;150(10):1095\u20131101."},{"issue":"4","key":"b23","series-title":"Acta Neuropathol","first-page":"613","article-title":"An update on the central nervous system manifestations of tuberous sclerosis complex","volume":"139","author":"Cotter JA","year":"2020","unstructured":"Cotter JA. An update on the central nervous system manifestations of tuberous sclerosis complex. Acta Neuropathol. 2020;139(4):613\u2013624."},{"key":"b24","series-title":"Pediatr Neurol","first-page":"81","article-title":"Acute management of symptomatic subependymal giant cell astrocytoma with everolimus","volume":"72","author":"Arroyo MS","year":"2017","unstructured":"Arroyo MS, Krueger DA, Broomall E, Stevenson CB, Franz DN. Acute management of symptomatic subependymal giant cell astrocytoma with everolimus. Pediatr Neurol. 2017;72:81\u201385."},{"key":"b25","series-title":"Front Neurol","first-page":"581102","article-title":"Maintenance therapy with everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis - final results from the EMINENTS study","volume":"12","author":"Bobeff K","year":"2021","unstructured":"Bobeff K, Krajewska K, Baranska D,  Maintenance therapy with everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis - final results from the EMINENTS study. Front Neurol. 2021;12:581102."},{"key":"b26","series-title":"J Pediatr","first-page":"151","article-title":"Safety of everolimus in patients younger than 3 years of age: results from EXIST-1, a randomized, controlled clinical trial","volume":"172","author":"J\u00f3\u017awiak S","year":"2016","unstructured":"J\u00f3\u017awiak S, Kotulska K, Berkowitz N, Brechenmacher T, Franz DN. Safety of everolimus in patients younger than 3 years of age: results from EXIST-1, a randomized, controlled clinical trial. J Pediatr. 2016;172:151\u2013155.e1."},{"issue":"4","key":"b27","series-title":"Neurosurg Focus","first-page":"E9","article-title":"Laser interstitial thermal therapy for subependymal giant cell astrocytoma: technical case report","volume":"41","author":"Dadey DY","year":"2016","unstructured":"Dadey DY, Kamath AA, Leuthardt EC, Smyth MD. Laser interstitial thermal therapy for subependymal giant cell astrocytoma: technical case report. Neurosurg Focus. 2016;41(4):E9."},{"issue":"5","key":"b28","series-title":"J Neurosurg Pediatr","first-page":"523","article-title":"Trapped ventricle after laser ablation of a subependymal giant cell astrocytoma complicated by intraventricular gadolinium extravasation: case report","volume":"21","author":"Karsy M","year":"2018","unstructured":"Karsy M, Patel DM, Bollo RJ. Trapped ventricle after laser ablation of a subependymal giant cell astrocytoma complicated by intraventricular gadolinium extravasation: case report. J Neurosurg Pediatr. 2018;21(5):523\u2013527."},{"issue":"3","key":"b29","series-title":"J Neurooncol","first-page":"731","article-title":"The effect of mTOR inhibition on obstructive hydrocephalus in patients with tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA)","volume":"147","author":"Weidman DR","year":"2020","unstructured":"Weidman DR, Palasamudram S, Zak M,  The effect of mTOR inhibition on obstructive hydrocephalus in patients with tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA). J Neurooncol. 2020;147(3):731\u2013736."},{"issue":"1","key":"b30","series-title":"Neurosciences (Riyadh)","first-page":"61","article-title":"Infantile atypical subependymal giant cell astrocytoma","volume":"25","author":"Almubarak AO","year":"2020","unstructured":"Almubarak AO, Abdullah J, Al Hindi H, AlShail E. Infantile atypical subependymal giant cell astrocytoma. Neurosciences (Riyadh). 2020;25(1):61\u201364."}],"container-title":["Journal of Neurosurgery: Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-pediatr\/32\/3\/article-p351.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-pediatr\/32\/3\/article-p351.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-pediatr\/32\/3\/article-p351.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T13:02:39Z","timestamp":1733490159000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-pediatr\/32\/3\/article-p351.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":30,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3171\/2023.5.peds23108","relation":{},"ISSN":["1933-0707","1933-0715"],"issn-type":[{"value":"1933-0707","type":"print"},{"value":"1933-0715","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,1]]}}}